The Procter & Gamble Company Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 44 rows in 2026. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2026-09-15: Reporting owner Bharucha Freddy P.; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2026-09-15: Reporting owner Purushothaman Balaji; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2026-09-15: Reporting owner Jejurikar Shailesh; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2026-09-15: Reporting owner Santos de Azevedo Juliana Monteiro; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
PG insiders transactions against the stock price
Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close
Logarithmic scale. Both lines share the same starting value for the selected range.
Markers: each transaction type positioned at that session's split-adjusted close. Tooltips retain the reported transaction price when available.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-09-15 | Bharucha Freddy P. Officer (CEO - Beauty) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,271 9,271 owned after | $146.67 exercise price | $146.67 | 2026-09-17 |
| 2026-09-15 | Purushothaman Balaji Officer (Chief Human Resources Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,336 12,336 owned after | $146.67 exercise price | $146.67 | 2026-09-17 |
| 2026-09-15 | Jejurikar Shailesh Director, Officer (Chairman, President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,787 22,787 owned after | $146.67 exercise price | $146.67 | 2026-09-17 |
| 2026-09-15 | Santos de Azevedo Juliana Monteiro Officer (CEO - Grooming) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,476 14,476 owned after | $146.67 exercise price | $146.67 | 2026-09-17 |
| 2026-09-15 | Aguilar Moses Victor Javier Officer (Chf Rsch, Dev & Innov Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,519 3,519 owned after | $146.67 exercise price | $146.67 | 2026-09-17 |
| 2026-07-10 holding as of filing | Santos de Azevedo Juliana Monteiro Officer (CEO - Grooming) | 3/A | Stock Option (Right to Buy) Derivative · Direct | Holding | $128.51 exercise price | 2026-07-10 | ||
| 2026-07-10 holding as of filing | Santos de Azevedo Juliana Monteiro Officer (CEO - Grooming) | 3/A | Stock Option (Right to Buy) Derivative · Direct | Holding | $145.19 exercise price | 2026-07-10 | ||
| 2026-07-10 holding as of filing | Santos de Azevedo Juliana Monteiro Officer (CEO - Grooming) | 3/A | Stock Option (Right to Buy) Derivative · Direct | Holding | $153.47 exercise price | 2026-07-10 | ||
| 2026-07-10 holding as of filing | Santos de Azevedo Juliana Monteiro Officer (CEO - Grooming) | 3/A | Stock Option (Right to Buy) Derivative · Direct | Holding | $173.04 exercise price | 2026-07-10 | ||
| 2026-07-10 holding as of filing | Santos de Azevedo Juliana Monteiro Officer (CEO - Grooming) | 3/A | Stock Option (Right to Buy) Derivative · Direct | Holding | $174.08 exercise price | 2026-07-10 | ||
| 2026-07-10 holding as of filing | Santos de Azevedo Juliana Monteiro Officer (CEO - Grooming) | 3/A | Stock Option (Right to Buy) Derivative · Direct | Holding | $153.18 exercise price | 2026-07-10 | ||
| 2026-07-10 holding as of filing | Santos de Azevedo Juliana Monteiro Officer (CEO - Grooming) | 3/A | Stock Option (Right to Buy) Derivative · Direct | Holding | $156.83 exercise price | 2026-07-10 | ||
| 2026-07-10 holding as of filing | Santos de Azevedo Juliana Monteiro Officer (CEO - Grooming) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $128.51 exercise price | 2026-07-10 | ||
| 2026-07-10 holding as of filing | Santos de Azevedo Juliana Monteiro Officer (CEO - Grooming) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $145.19 exercise price | 2026-07-10 | ||
| 2026-07-10 holding as of filing | Santos de Azevedo Juliana Monteiro Officer (CEO - Grooming) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $153.47 exercise price | 2026-07-10 | ||
| 2026-07-10 holding as of filing | Santos de Azevedo Juliana Monteiro Officer (CEO - Grooming) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $173.04 exercise price | 2026-07-10 | ||
| 2026-07-10 holding as of filing | Santos de Azevedo Juliana Monteiro Officer (CEO - Grooming) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $174.08 exercise price | 2026-07-10 | ||
| 2026-07-10 holding as of filing | Santos de Azevedo Juliana Monteiro Officer (CEO - Grooming) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $153.18 exercise price | 2026-07-10 | ||
| 2026-07-10 holding as of filing | Santos de Azevedo Juliana Monteiro Officer (CEO - Grooming) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $156.83 exercise price | 2026-07-10 | ||
| 2026-06-08 holding as of filing | Abd El Hak Hesham Officer (CEO-Baby and Feminine Care) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $113.23 exercise price | 2026-06-08 | ||
| 2026-06-08 holding as of filing | Abd El Hak Hesham Officer (CEO-Baby and Feminine Care) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $139.24 exercise price | 2026-06-08 | ||
| 2026-06-08 holding as of filing | Abd El Hak Hesham Officer (CEO-Baby and Feminine Care) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $139.58 exercise price | 2026-06-08 | ||
| 2026-06-08 holding as of filing | Abd El Hak Hesham Officer (CEO-Baby and Feminine Care) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $128.51 exercise price | 2026-06-08 | ||
| 2026-06-08 holding as of filing | Abd El Hak Hesham Officer (CEO-Baby and Feminine Care) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $137.44 exercise price | 2026-06-08 | ||
| 2026-06-08 holding as of filing | Abd El Hak Hesham Officer (CEO-Baby and Feminine Care) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $145.19 exercise price | 2026-06-08 | ||
| 2026-06-08 holding as of filing | Abd El Hak Hesham Officer (CEO-Baby and Feminine Care) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $153.47 exercise price | 2026-06-08 | ||
| 2026-06-08 holding as of filing | Abd El Hak Hesham Officer (CEO-Baby and Feminine Care) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $173.04 exercise price | 2026-06-08 | ||
| 2026-06-08 holding as of filing | Abd El Hak Hesham Officer (CEO-Baby and Feminine Care) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $174.08 exercise price | 2026-06-08 | ||
| 2026-06-08 holding as of filing | Abd El Hak Hesham Officer (CEO-Baby and Feminine Care) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $153.18 exercise price | 2026-06-08 | ||
| 2026-06-08 holding as of filing | Abd El Hak Hesham Officer (CEO-Baby and Feminine Care) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $156.83 exercise price | 2026-06-08 | ||
| 2026-04-07 holding as of filing | Gama Paul Officer (CEO- Health Care) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $113.23 exercise price | 2026-04-07 | ||
| 2026-04-07 holding as of filing | Gama Paul Officer (CEO- Health Care) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $139.24 exercise price | 2026-04-07 | ||
| 2026-04-07 holding as of filing | Gama Paul Officer (CEO- Health Care) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $138.63 exercise price | 2026-04-07 | ||
| 2026-04-07 holding as of filing | Gama Paul Officer (CEO- Health Care) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $139.58 exercise price | 2026-04-07 | ||
| 2026-04-07 holding as of filing | Gama Paul Officer (CEO- Health Care) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $145.12 exercise price | 2026-04-07 | ||
| 2026-04-07 holding as of filing | Gama Paul Officer (CEO- Health Care) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $128.51 exercise price | 2026-04-07 | ||
| 2026-04-07 holding as of filing | Gama Paul Officer (CEO- Health Care) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $145.19 exercise price | 2026-04-07 | ||
| 2026-04-07 holding as of filing | Gama Paul Officer (CEO- Health Care) | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $173.04 exercise price | 2026-04-07 | ||
| 2026-02-13 | Aguilar Moses Victor Javier Officer (Chf Rsch, Dev & Innov Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,169 0 owned after | $91.07 exercise price | $160.07 | 2026-02-17 |
| 2026-02-12 | Moeller Jon R Director, Officer (Exec. Chairman of the Board) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −162,232 0 owned after | $113.23 exercise price | $161.21 | 2026-02-13 |
| 2026-02-12 | Coombe Gary A Officer (CEO - Grooming) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −36,093 36,093 owned after | $78.52 exercise price | $161.21 | 2026-02-13 |
| 2026-02-11 | Purushothaman Balaji Officer (Chief Human Resources Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,827 0 owned after | $91.07 exercise price | $160.00 | 2026-02-13 |
| 2026-02-11 | Moeller Jon R Director, Officer (Exec. Chairman of the Board) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,036 162,232 owned after | $113.23 exercise price | $160.00 | 2026-02-13 |
| 2026-01-23 | Pritchard Marc S. Officer (Chief Brand Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −95,903 0 owned after | $80.29 exercise price | $150.15 | 2026-01-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| Longevity Health Holdings, Inc. (XAGE) | United States | $0.006B | -0.09 |